Source: Revenio Group Oyj
Revenio Group Corporation Stock Exchange Release 4 December 2013 at 08:50
INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER
7,445 new share subscriptions based on the company's 2007B stock options by
the number of 5,000 and 2007C stock options by the number of 2,445 approved
by the Board of Directors of Revenio Group Corporation on 25 November 2013,
have been entered into the trade register today. The share subscription
price under 2007B option rights is 2.35 per share and under 2007C option
rights EUR 2.29 per share. The subscription period for 2007B options is from
1 November 2010 to 1 November 2014 and for 2007C options from 1 May 2012 to
1 May 2016.
After these subscriptions, the number of Revenio Group Corporation's shares
and votes will rise to 7,850,749. These increases were recorded in their
entirety in the unrestricted shareholders' equity fund.
Revenio Group Corporation has applied for the listing of its new shares on
NASDAQ OMX Helsinki in the same series as the company's existing shares.
According to the current estimate, the new shares will be listed on 5
Revenio Group Corporation
President and CEO
For further information, please contact:
Olli-Pekka Salovaara, President & CEO, +358 (0)40 567 5520 (mobile)
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is tonometers.
Revenio Health Tech segment comprises the operations of Icare Finland Oy.
widely patented Icare product family is the current cornerstone of the
success. Revenio seeks vigorous growth in health technology, both
and through acquisitions and mergers.
The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products
services in their industry. These businesses are extremely profitable in
industries and generate positive cash flow.
In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.